Articles

1. Developing A Strategic Relationship – Amgen And PRA 6/21/2012

   When new opportunities arise and sponsor companies are vetting CROs or partners for their work, they look first to their existing relationships. Then, particularly for new development areas such as biosimilars, they look at the entire landscape for other organizations that have specific expertise in that field. By Rob Wright

2. Kemwell Overview 3/29/2012
   Manufacturing customers include top pharmaceutical companies – Allergan, Bayer, GSK, J&J, Pfizer, Teva, and Novartis, as well as small emerging biotech.
3. Sterile Clinical Trial Material Formulation & Filling 3/26/2012
   DSM offers sterile clinical trial formulation and filling that meets the unique needs of global pharmaceutical and biotech customers.
4. Cardiovascular Services Brochure 3/14/2012
   A leading western CRO in Russia, ClinStar offers invaluable experience and medical support to enhance your study execution, resulting in higherquality results. We offer local regulatory, customs and logistical expertise as well as clinical teams that are therapeutically trained in cardiovascular diseases.
5. Brochure: RHOBUST® Downstream Processing Technology 2/22/2012
   Rhobust® technology is a downstream processing technology for the manufacturing of recombinant proteins and antibodies.
6. Brochure: XD® Technology: Improve Biopharmaceutical Production 2/22/2012
   DSM's XD® Technology has been developed to drive yield improvements in the production of biopharmaceuticals.
7. Brochure: Biologics Contract Manufacturing & Technology Solutions 1/30/2012

   DSM provides turn-key biologic manufacturing solutions, contract manufacturing for preclinical development, clinical trials or commercial supply and reduced cost, risk, and time to market.

8. Alkermes Contract Pharma Services 9/28/2011

   With Alkermes Contract Pharma Services, you have the opportunity to outsource your development, scale-up and manufacturing requirements to a trusted, experienced and dedicated expert in outsourcing services.

9. Clinical Trials In Russia 8/26/2011
   The Federal Service on Surveillance in Healthcare and Social Development of the Russian Federation (Roszdravnadzor) and the Ministry of Health and Social Development of the Russian Federation (MoH) approved 492 new clinical trials of all types including local and bioequivalence studies during 2010, demonstrating a 15% decrease from the last year figure.
10. Case Study: Flu Vaccine Trial Accelerated Despite Late-In-Season Start 5/11/2011
    Streamlined processes for study startup, coupled with experience in vaccine trials and solid relationships with study sites and investigators, helped this Quintiles team meet the challenge of starting an influenza vaccine trial late in the influenza season.